Mealey's (March 28, 2019, 12:38 PM EDT) -- ALEXANDRIA, Va. — In a March 26 final written decision, the Patent Trial and Appeal Board rejected allegations by an inter partes review (IPR) petitioner that a system for rapid skin cancer screening is unpatentable as obvious (Canfield Scientific Inc. v. Melanoscan LLC, No. IPR2017-02125, PTAB)....